Medicare Enrolled

Dr. Adam Hsu, M.D.

Ophthalmic Plastic and Reconstructive Surgery Physician · City Of Industry, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
18575 GALE AVE, City Of Industry, CA 91748
6268100689
In practice since 2007 (19 years)
NPI: 1699825083 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hsu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hsu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hsu

Dr. Adam Hsu is an ophthalmic plastic and reconstructive surgery physician in City Of Industry, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hsu performed 1,743 Medicare services across 1,510 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hsu received a total of $3,144 from 24 pharmaceutical and/or device companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmic plastic and reconstructive surgery physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hsu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 32% volume in CA $3,144 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,743
Medicare services
Top 32% in CA for ophthalmic plastic and reconstructive surgery physician
1,510
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~92 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
453 $79 $199
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
420 $61 $160
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
335 $26 $100
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
199 $45 $186
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
146 $95 $300
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
53 $77 $180
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
42 $25 $100
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
38 $22 $60
Eyelash removal with forceps
This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area.
29 $13 $107
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
28 $7 $40
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,144
Total received (2018-2024)
Avg $449/year across 7 years
Top 31% in CA for ophthalmic plastic and reconstructive surgery physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
158
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,142 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$610
2023
$473
2022
$499
2021
$609
2020
$375
2019
$169
2018
$408

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$212
Alcon Vision LLC
$87
Bausch & Lomb Americas Inc.
$81
Oyster Point Pharma, Inc.
$71
ABBVIE INC.
$36
Harrow Eye, LLC
$31
SUN PHARMACEUTICAL INDUSTRIES INC.
$26
Merz Pharmaceuticals, LLC
$25
Optos, Inc.
$23
Thea Pharma Inc.
$18
Top 3 companies account for 62.3% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$731
Shire North American Group Inc
$298
Allergan, Inc.
$280
Alcon Vision LLC
$250
Merz Pharmaceuticals, LLC
$241
Amgen Inc.
$212
Aerie Pharmaceuticals, Inc.
$208
Oyster Point Pharma, Inc.
$163
Bausch & Lomb Americas Inc.
$117
Sight Sciences, Inc.
$109
Novartis Pharmaceuticals Corporation
$107
ABBVIE INC.
$105
Sun Pharmaceutical Industries Inc.
$62
Optos, Inc.
$41
SUN PHARMACEUTICAL INDUSTRIES INC.
$41
Harrow Eye, LLC
$31
Dompe US, Inc.
$28
Mallinckrodt Hospital Products Inc.
$25
Bausch & Lomb, a division of Bausch Health US, LLC
$23
BioTissue Holdings, Inc.
$18
Thea Pharma Inc.
$18
EYEVANCE PHARMACEUTICALS LLC
$16
Eyevance Pharmaceuticals LLC
$15
Travere Therapeutics, Inc.
$2
Top 3 companies account for 41.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BROMSITE · Cequa · Cholbam · DURYSTA · Flarex · IYUZEH · LUMIGAN · MIEBO · NFC-700 · OMNI Surgical System · OXERVATE · PROKERA · RESTASIS · RESTASIS MULTIDOSE · Rhopressa · Rocklatan · TEPEZZA · TRAVATAN Z · TYRVAYA · VEVYE · VUITY · VYZULTA · XIIDRA · Xeomin · ZERVIATE · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmic plastic and reconstructive surgery physician in City Of Industry?
Compare ophthalmic plastic and reconstructive surgery physicians in the City Of Industry area by procedure volume, costs, and industry payment transparency.
Browse ophthalmic plastic and reconstructive surgery physicians nearby

Geographic Context

Ophthalmic plastic and reconstructive surgery physicians within 10 mi
9
Per 100K population
0.1
County median income
$87,760
Nearest hospital
PROVIDENCE ST. JUDE MEDICAL CENTER
5.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hsu is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hsu experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Hsu performed 453 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hsu receive payments from pharmaceutical companies?
Yes. Dr. Hsu received a total of $3,144 from 24 companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hsu's costs compare to other ophthalmic plastic and reconstructive surgery physicians in City Of Industry?
Dr. Hsu's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hsu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →